The recent approval of COVID-19 vaccines for emergency use by India’s regulator paves the way for actual vaccination to begin. In fact, preparations have been underway for quite some time. Vaccine production lines have been running to produce millions of doses even before clinical trials were concluded – a testament to the ability to innovate, even at significant financial risk.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2LFze1p
via IFTTT
0 comments:
Post a Comment